{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T10:30:49Z","timestamp":1724668249895},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00063-016-0176-6","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T09:28:32Z","timestamp":1464859712000},"page":"434-439","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thrombotische Mikroangiopathien"],"prefix":"10.1007","volume":"111","author":[{"given":"M.","family":"Gaggl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sunder-Plassmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"key":"176_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","volume":"67","author":"CM Nester","year":"2015","unstructured":"Nester CM, Barbour T, Cordoba SR de, Dragon-Durey MA, Fremeaux-Bacchi V, Goodship TH, Kavanagh D, Noris M, Pickering M, Sanchez-Corral P, Skerka C, Zipfel P, Smith RJ (2015) Atypical aHUS: State of the art. Mol Immunol 67:31\u201342","journal-title":"Mol Immunol"},{"key":"176_CR2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654\u2013666","journal-title":"N Engl J Med"},{"key":"176_CR3","first-page":"21","volume":"24","author":"E Moschcowitz","year":"1924","unstructured":"Moschcowitz E (1924) Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc 24:21\u201324","journal-title":"Proc N Y Pathol Soc"},{"key":"176_CR4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1345\/aph.1G067","volume":"39","author":"M Huynh","year":"2005","unstructured":"Huynh M, Chee K, Lau DH (2005) Thrombotic thrombocytopenic purpura associated with quetiapine. Ann Pharmacother 39:1346\u20131348","journal-title":"Ann Pharmacother"},{"key":"176_CR5","first-page":"905","volume":"85","author":"C Gasser","year":"1955","unstructured":"Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R (1955) Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr 85:905\u2013909","journal-title":"Schweiz Med Wochenschr"},{"key":"176_CR6","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood-2015-03-569277","volume":"126","author":"EM Conway","year":"2015","unstructured":"Conway EM (2015) HUS and the case for complement. Blood 126:2085\u20132090","journal-title":"Blood"},{"key":"176_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM (2009) Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 361:345\u2013357","journal-title":"N Engl J Med"},{"key":"176_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","volume":"25","author":"F Bu","year":"2014","unstructured":"Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, Smith RJ (2014) Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J\u00a0Am Soc Nephrol 25:55\u201364","journal-title":"J Am Soc Nephrol"},{"key":"176_CR9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","volume":"45","author":"M Lemaire","year":"2013","unstructured":"Lemaire M, Fremeaux-Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, Fakhouri F, Taque S, Nobili F, Martinez F, Ji W, Overton JD, Mane SM, Nurnberg G, Altmuller J, Thiele H, Morin D, Deschenes G, Baudouin V, Llanas B, Collard L, Majid MA, Simkova E, Nurnberg P, Rioux-Leclerc N, Moeckel GW, Gubler MC, Hwa J, Loirat C, Lifton RP (2013) Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet 45:531\u2013536","journal-title":"Nat Genet"},{"key":"176_CR10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-3476(05)81967-5","volume":"120","author":"MT Geraghty","year":"1992","unstructured":"Geraghty MT, Perlman EJ, Martin LS, Hayflick SJ, Casella JF, Rosenblatt DS, Valle D (1992) Cobalamin C defect associated with hemolytic-uremic syndrome. J Pediatr 120:934\u2013937","journal-title":"J Pediatr"},{"key":"176_CR11","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","volume":"5","author":"H Sartelet","year":"2005","unstructured":"Sartelet H, Toupance O, Lorenzato M, Fadel F, Noel LH, Lagonotte E, Birembaut P, Chanard J, Rieu P (2005) Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys. Am J Transplant 5:2441\u20132447","journal-title":"Am J Transplant"},{"key":"176_CR12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129\u20131136","journal-title":"N Engl J Med"},{"key":"176_CR13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1517\/14740330902942299","volume":"8","author":"MW Saif","year":"2009","unstructured":"Saif MW, Xyla V, Makrilia N, Bliziotis I, Syrigos K (2009) Thrombotic microangiopathy associated with gemcitabine: rare but real. Expert Opin Drug Saf 8:257\u2013260","journal-title":"Expert Opin Drug Saf"},{"key":"176_CR14","first-page":"14","volume":"91","author":"RF Webb","year":"1980","unstructured":"Webb RF, Ramirez AM, Hocken AG, Pettit JE (1980) Acute intravascular haemolysis due to quinine. N Z Med J 91:14\u201316","journal-title":"N Z Med J"},{"key":"176_CR15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.hoc.2015.01.009","volume":"29","author":"AM Risitano","year":"2015","unstructured":"Risitano AM (2015) Current and future pharmacologic complement inhibitors. Hematol Oncol Clin North Am 29:561\u2013582","journal-title":"Hematol Oncol Clin North Am"},{"key":"176_CR16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel PF, Skerka C (2009) Complement regulators and inhibitory proteins. Nat Rev Immunol 9:729\u2013740","journal-title":"Nat. Rev. Immunol."},{"key":"176_CR17","first-page":"27","volume":"33","author":"JM Campistol","year":"2013","unstructured":"Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa M, Grinyo JM, Praga M, Torra R, Vilalta R, Rodriguez de Cordoba S (2013) An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia 33:27\u201345","journal-title":"Nefrologia"},{"issue":"11","key":"176_CR18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","volume":"8","author":"M Noris","year":"2012","unstructured":"Noris M, Mescia F, Remuzzi G (2012) STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 8(11):622\u2013633","journal-title":"Nat Rev Nephrol"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-016-0176-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-016-0176-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-016-0176-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T05:09:59Z","timestamp":1568005799000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-016-0176-6"}},"subtitle":["Relevante Neuigkeiten f\u00fcr\u00a0den\u00a0Intensivmediziner"],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["176"],"URL":"https:\/\/doi.org\/10.1007\/s00063-016-0176-6","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}